IR 4 SPRL
The score of IR 4 shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -10 % Total assets +1 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
IR 4's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 23 Feb 2026
- Year ended 30 Jun 2024filed on 31 Jan 2025
- Year ended 30 Jun 2023filed on 25 Jan 2024
- Year ended 30 Jun 2022filed on 09 Feb 2023
- Year ended 30 Jun 2021filed on 25 Jan 2022
IR 4's financial analysis
- Solvency45.6%sector median: 45.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of IR 4
IR 4's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0808.640.401
- VAT number
- BE0808640401
- Peppol
- Registered · 0208:0808640401 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 23 Dec 2008
- Registered office
- 1160 Auderghem
- Latest accounts
- 2025 · filed on 23 Feb 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
IR 4 (SPRL) has been based in Auderghem since 2008, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 4,853 € and equity of 394,238 €; its revenue is not published. Its solvency stands at 45.6%, below the median of its sector (45.7%).
Companies similar to IR 4
Companies in the same business, of comparable size and area, outside its group.
- Dokter Fries Claerhout Research and experimental development on natural sciences and engineering Poperinge · balance sheet 906,181 €
- Temple OrthoBiologics Research and experimental development on natural sciences and engineering Liège · balance sheet 692,165 €
- Nyemb Research and experimental development on natural sciences and engineering Tournai · balance sheet €1.15m
- NasaPharm Research and experimental development on natural sciences and engineering Blegny · balance sheet 606,267 €
- ProtonW.be Research and experimental development on natural sciences and engineering Charleroi · balance sheet €1.27m
- Asylia Diagnostics Research and experimental development on natural sciences and engineering Leuven · balance sheet 552,090 €
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
- DR. Johan Vanden Broucke Research and experimental development on natural sciences and engineering Ypres · balance sheet €1.88m
Frequently asked questions about IR 4
What is the revenue of IR 4?
IR 4 files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of IR 4?
In Belgium, the VAT number is the company number prefixed with BE: BE0808640401 for IR 4, if the company is VAT-registered. Its company number (CBE) is 0808.640.401.
Where is the registered office of IR 4?
According to the CBE register, the registered office of IR 4 is in 1160 Auderghem.
What is the equity of IR 4?
At the close of the 2025 financial year, the equity of IR 4 amounts to 394,238 €, a solvency of 45.6% of total assets.
Who manages IR 4?
The register lists 1 active mandates at IR 4. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of IR 4
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →